Timing of arrhythmic death after myocardial infarction: Does it affect timing of ICD implantation?

European Heart Journal

Volumn 26, Issue 14, 2005, Pages 1350-1352

  Lombardi, Federico ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD CLOT LYSIS; CLINICAL TRIAL; DEFIBRILLATOR; EDITORIAL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; IMPLANTATION; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; RISK ASSESSMENT; RISK REDUCTION;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MYOCARDIAL INFARCTION; TIME FACTORS;

EID: 25444456892     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi314     Document Type: Editorial

References (11)

1. Antman EA. ST-elevation myocardial infarction: management. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease. Philadelphia PA: Elsevier Saunders; 2005. p1167-1226.
2. Moss AJ, Zareba W, Hall WJ, Higgins S, Klein H, Wlber D, Zareba W, Brown M. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
3. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemaker and antiarrhythmia devices-summary article: a report of the American College of cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2002; 40:1703-1719.
4. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm JA, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pederesen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJJ, Zipes D. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003;24:13-15.
5. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Teck M, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ on behalf of the DINAMIT investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351: 2481-2488.
6. Yap YG, Duong T, Bland JMM, Torp-Pedersen C, Kober L, Connolly SJ, Marchant B, Camm AJ. Temporal trends on the risk of arrhythmic versus non-arrhythmic deaths in high-risk patients after myocardial infarction. A combined analysis from multi-centre trials. Eur Heart J 2005;26:1385-1393. First published on May 24, 2005, doi:10.1093/eurheartj/ehi268.
7. Tapanainen JM, Still AM, Airaksinen KEJ, Huikuri HV. Prognostic significance of risk stratifiers of mortality including T-wave alternans, after acute myocardial infarction: results of a prospective follow-up study. J Cardiovasc Electrophysiol 2001;12:645-652.
8. Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, Pires LA, Gold MR, Packer DL, Josephson ME, Prystowsky EN, Talajic MR for the MUSST investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease. An analysis of patients enrolled in the Multicenter Unsustained Ventricular tachycardia Trial. Circulation 2002;106:2466-2472.
9. Lombardi F. Clinical implications of present physiological understanding of HRV components. Cardiac Electrophysioll Rev 2002; 6:245-249.
10. Hohnloser SH, Ikeda T, Bloomfield DM, Babbous OH, Cohen RJ. T-wave alternans negative coronary patients with low ejection fraction and benefit from defibrillator implantation. Lancet 2003;362:125-126.
11. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardioverter defibrillator therapy. A solution to the Multicenter Automatic defibrillator Implantation Trail (MADIT) II conundrum. Circulation 2004;110:1885-1889.